C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2006
11/02/2006	US20060247262 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247237 Macrocyclic quinazoline derivatives as antiproliferative agents
11/02/2006	US20060247229 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	EP1717232A1 Phenylsulfonylureas with herbicidal activity
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716867A1 Preventives for migraine
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	CA2808289A1 Process for the preparation of an intermediate useful in production of azoxystrobin
11/02/2006	CA2607473A1 Herbicidally active phenylsulphonyl-urea
11/02/2006	CA2605480A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006	CA2605323A1 Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	CA2604518A1 Phenyl ethyne compounds
11/01/2006	CN1856480A P-38 kinase inhibitors
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1854130A Chinazoline derivative, its production, medicinal composition and use
11/01/2006	CN1854129A Superhigh purity ionic liquid
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1282642C Intermediates for preparing aminophenylsulfonylureas and preparation method therefor
10/2006
10/31/2006	US7129518 organometallic iridium complexes used as light emitting layers in organic light emitting diodes, having layers of charge transfer compounds
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129353 Reacting 4,6-dihydroxy-5-fluoropyrimidine compound with phosgene in presence of nitrobenzene solvent, optionally in presence of 1-dimethylaminopyridine as catalyst
10/31/2006	US7129352 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129239 Dietetics; cardiovascular disorders; strokes; antidiabetic agents, sleep disorders, osteoporosis
10/31/2006	US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006	CA2256415C Substituted phenyl uracils
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/31/2006	CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/31/2006	CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006	WO2006113650A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs
10/26/2006	WO2006111346A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/26/2006	US20060241298 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
10/26/2006	US20060241180 Selective androgen receptor modulators and methods of use thereof
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241120 Cannabinoid Receptor Ligands and Uses Thereof
10/26/2006	US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006	DE102005018191A1 Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln Substituted cyclic urea derivatives and their use for the preparation of medicaments
10/26/2006	CA2606174A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
10/26/2006	CA2605144A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
10/26/2006	CA2604942A1 2-amino-quinaz0lin-5-ones
10/26/2006	CA2604581A1 Combinations, methods and compositions for treating cancer
10/25/2006	EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006	EP1713793A2 Pyrimidinone compounds useful as kinase inhibitors
10/25/2006	EP1713782A1 Pth agonists
10/25/2006	EP1713781A1 Quinazoline derivatives
10/25/2006	EP1713775A2 Chemical compounds
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof
10/25/2006	EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl\|-pyrazol- 1,5-alpha\|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
10/25/2006	CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
10/25/2006	CN1852899A Polymorphic forms of a known antihyperlipemic agent
10/25/2006	CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors
10/25/2006	CN1850807A Gefitinib synthesis intermediate, and its preparing method and use
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/24/2006	US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006	US7125996 Fluorescent probes for use in protein kinase inhibitor binding assay
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125993 A2B adenosine receptor antagonists
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125880 Corticotropin releasing factor antagonists
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125428 1,3-Dihydroxybenzene derivatives and colorants containing said compounds
10/24/2006	CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
10/24/2006	CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators
10/24/2006	CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/19/2006	WO2006109817A1 1,4-substituted piperazine derivative
10/19/2006	WO2006108773A1 (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
10/19/2006	WO2006108714A2 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
10/19/2006	WO2006108713A2 1-amino-1, 2,3,4-tetrahydro-naphthaline-2-ol derivates as anti-inflammatory agents
10/19/2006	WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006	WO2006108224A1 Antiparasitic compounds
10/19/2006	WO2006069395A3 Synthetic process for the preparation of biocyclic compounds
10/19/2006	WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use
10/19/2006	US20060235223 Variolin derivatives and their use as antitumor agents
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor

1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 427